February 15, 2017
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on H.R. 1038, legislation introduced by Reps. Morgan Griffith (R-VA) and Peter Welch (D-VT), that would prohibit Medicare Part D plans from using direct and indirect remuneration (DIR) for pharmacies in Part D:
“Medicare Part D is overwhelmingly popular with a 90% satisfaction rate among enrollees. While this bill might increase drugstore profits, it would raise premiums for beneficiaries and increase costs for taxpayers.
A recent report by the Centers for Medicare & Medicaid Services highlights how DIR reduces premiums for beneficiaries, which also leads to lower costs for the federal government.”